her2climb: investigating tucatinib with capecitabine and trastuzumab in her2-positive metastatic...
Published 4 years ago • 818 plays • Length 5:50Download video MP4
Download video MP3
Similar videos
-
2:01
her2climb: tucatinib in combination w/ capecitabine & trastuzumab
-
2:33
her2climb: tucatinib with trastuzumab and capecitabine for her2 breast cancer with brain metastases
-
1:11
her2climb: tucatinib efficacious against brain metastases in patients with her2 breast cancer
-
1:51
tucatinib combination improved survival in her2–positive breast cancer
-
2:35
tucatinib with capecitabine and trastuzumab in advanced her2-positive breast cancer
-
5:14
her2 mbc: systemic therapies and her2climb-02 trial
-
7:38
tucatinib plus trastuzumab & capecitabine for patients with her2-positive breast cancer & brain mets
-
1:12
her2climb-04: tucatinib trastuzumab deruxtecan in her2 breast cancer
-
1:47
her2climb-05: tucatinib trastuzumab and pertuzumab as maintenance therapy for her2 metastatic bc
-
4:46
mountaineer: tucatinib in combination with trastuzumab for her2-positive metastatic colorectal c...
-
4:30
tucatinib for the treatment of her2 breast cancer
-
4:44
an overview of recent metastatic her2 breast cancer trials
-
3:15
her2climb-02: tucatinib tdm-1 in advanced breast cancer
-
1:40
her2climb study shows efficacy in her2 breast cancer with brain metastases
-
1:52
her2climb regimen can be used earlier in her2 metastatic breast cancer
-
1:16
her2climb-04: tucatinib plus t-dxd for her2 breast cancer
-
0:36
tucatinib & trastuzumab /- chemo or pembrolizumab in unresectable or metastatic her2 gi cancers
-
4:42
t-dm1 may extend pfs among patients with unresectable locally advanced or metastatic her2-positi...
-
5:25
her2climb fda approval